BRPI0817484A2 - Composições compreendendo antígeno, composto anfipático e um veículo hidrofóbico e o uso dos mesmos - Google Patents

Composições compreendendo antígeno, composto anfipático e um veículo hidrofóbico e o uso dos mesmos

Info

Publication number: BRPI0817484A2
Authority: BR; Brazil
Prior art keywords: antigen; compositions; hydrophobic carrier; amphipathic compound; amphipathic
Prior art date: 2007-10-03

Application number

Other languages

English (en)

Inventor

Marc Mansour

Original Assignee

Immunovaccine Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-03

Filing date

2008-10-02

Publication date

2015-03-24

2008-10-02 Application filed by Immunovaccine Technologies Inc filed Critical Immunovaccine Technologies Inc

2015-03-24 Publication of BRPI0817484A2 publication Critical patent/BRPI0817484A2/pt

2021-08-17 Publication of BRPI0817484B1 publication Critical patent/BRPI0817484B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Mycology (AREA)
Microbiology (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Addiction (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Otolaryngology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)

BRPI0817484-9A 2007-10-03 2008-10-02 Composição de vacina sem água, processo de produção e o uso dos mesmos BRPI0817484B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US97719707P	2007-10-03	2007-10-03
US60/977,197		2007-10-03
PCT/CA2008/001747 WO2009043165A1 (en)	2007-10-03	2008-10-02	Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof

Publications (2)

Publication Number	Publication Date
BRPI0817484A2 true BRPI0817484A2 (pt)	2015-03-24
BRPI0817484B1 BRPI0817484B1 (pt)	2021-08-17

Family

ID=40525804

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817484-9A BRPI0817484B1 (pt)	2007-10-03	2008-10-02	Composição de vacina sem água, processo de produção e o uso dos mesmos

Country Status (7)

Country	Link
EP (1)	EP2195022A4 (pt)
JP (1)	JP5591705B2 (pt)
CN (1)	CN101815529B (pt)
AU (1)	AU2008307042B2 (pt)
BR (1)	BRPI0817484B1 (pt)
CA (1)	CA2700828C (pt)
WO (1)	WO2009043165A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5731198B2 (ja)	2007-09-27	2015-06-10	イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
JP5715051B2 (ja)	2008-06-05	2015-05-07	イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物
US10105435B2 (en) *	2011-10-06	2018-10-23	Immunovaccine Technologies Inc.	Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
ES2702622T3 (es)	2013-03-27	2019-03-04	Immunovaccine Technologies Inc	Método para mejorar la eficacia de una vacuna de survivina en el tratamiento de cáncer
CA2972635A1 (en)	2015-01-06	2016-07-14	Immunovaccine Technologies Inc.	Lipid a mimics, methods of preparation, and uses thereof
CN105044328A (zh) *	2015-05-28	2015-11-11	首都医科大学附属北京佑安医院	Elispot预包被培养板及其制备方法
EP3377099A4 (en) *	2015-11-18	2019-07-24	ImmunoVaccine Technologies Inc.	ADJUVANT SYSTEMS AND WATER-FREE VAPOR COMPOSITION OF ONE POLYI: C-POLYNUCLEOTIDADJUVANS AND ADJUVANS ON LIPID BASE
CN109328070A (zh) *	2016-05-04	2019-02-12	免疫疫苗技术有限公司	包含两亲化合物、新抗原和疏水载体的疫苗组合物及其使用方法
US11406705B2 (en)	2016-09-27	2022-08-09	Immunovaccine Technologies Inc.	Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
IL302880A (en)	2017-04-04	2023-07-01	Avidea Tech Inc	Peptide-based ingredients, production methods, and their uses for inducing an immune response
JP2021518373A (ja) *	2018-03-20	2021-08-02	イミューノヴァクシーンテクノロジーズインコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	活性剤及び免疫調節剤のリンパ節への標的化送達のための方法及び組成物
AU2022224567A1 (en) *	2021-02-16	2023-08-24	Barinthus Biotherapeutics North America, Inc.	Self-assembling nanoparticles based on amphiphilic peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU94040856A (ru) *	1992-03-03	1996-08-20	Дайити Фармасьютикал Ко.	Вакцина для перорального введения
US5736141A (en) *	1992-06-05	1998-04-07	Dalhousie University	Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
GB9422990D0 (en) *	1994-11-15	1995-01-04	Cortecs Ltd	Immunogenic compositions
AU8053898A (en) *	1997-05-28	1998-12-30	Jenner Biotherapies, Inc.	Immunogenic compositions
US6565885B1 (en) *	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6956021B1 (en) *	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
AU2002214861B2 (en) *	2000-11-07	2006-09-28	Immunovaccine Technologies Inc.	Vaccines with enhanced immune response and methods for their preparation
CA2523032A1 (en) *	2005-10-07	2007-04-07	Immunovaccine Technologies Inc.	Vaccines for cancer therapy

2008
- 2008-10-02 AU AU2008307042A patent/AU2008307042B2/en not_active Ceased
- 2008-10-02 EP EP08800418A patent/EP2195022A4/en not_active Withdrawn
- 2008-10-02 CN CN200880110239.7A patent/CN101815529B/zh not_active Expired - Fee Related
- 2008-10-02 BR BRPI0817484-9A patent/BRPI0817484B1/pt not_active IP Right Cessation
- 2008-10-02 JP JP2010527303A patent/JP5591705B2/ja not_active Expired - Fee Related
- 2008-10-02 WO PCT/CA2008/001747 patent/WO2009043165A1/en not_active Ceased
- 2008-10-02 CA CA2700828A patent/CA2700828C/en active Active

Also Published As

Publication number	Publication date
WO2009043165A1 (en)	2009-04-09
AU2008307042B2 (en)	2014-01-30
CA2700828C (en)	2017-01-24
JP5591705B2 (ja)	2014-09-17
CN101815529A (zh)	2010-08-25
CN101815529B (zh)	2016-03-09
EP2195022A1 (en)	2010-06-16
CA2700828A1 (en)	2009-04-09
JP2010540570A (ja)	2010-12-24
BRPI0817484B1 (pt)	2021-08-17
AU2008307042A1 (en)	2009-04-09
EP2195022A4 (en)	2012-08-01

Publication	Publication Date	Title
BRPI0817484A2 (pt)	2015-03-24	Composições compreendendo antígeno, composto anfipático e um veículo hidrofóbico e o uso dos mesmos
BRPI0618904A2 (pt)	2016-09-13	composto, composição farmacêutica, e, uso do composto
BRPI0614205A2 (pt)	2016-11-22	composto, composição farmacêutica, e, uso de composto
BRPI0907453A2 (pt)	2015-07-14	Compostos, uso e preparação dos mesmos
BRPI0815709A2 (pt)	2017-06-13	composro, composição farmacêutica, e, uso de um composto.
BRPI0716171A2 (pt)	2013-09-17	composto, composiÇço farmacÊutica e uso de um composto.
BRPI0722081A2 (pt)	2014-04-01	Complexo metálico, composto polimérico e dispositivo contendo os mesmos
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
BRPI0716327A2 (pt)	2014-03-04	Composto de fenilpropionamida e uso
BRPI0609802A2 (pt)	2017-05-02	composto, composição farmacêutica e uso de um composto
BRPI0813457A2 (pt)	2014-12-23	Composto de organoenxofre contendo halogênio e uso do mesmo
BRPI0821668A2 (pt)	2015-06-16	Uso
BRPI0922435A2 (pt)	2018-09-11	"composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
BRPI0915134A2 (pt)	2016-02-16	composto, e, uso de um composto
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BRPI0810019A2 (pt)	2014-10-14	Composto, composição farmacêutica, e, uso de um composto
BRPI0716698A2 (pt)	2014-02-25	Composto, composição farmacêutica e uso de um composto
BRPI0816084A2 (pt)	2015-02-24	Composto de organoenxofre contendo flúor e composição pesticida compreendendo o mesmo
BRPI0813587A2 (pt)	2014-12-30	Composto, uso do mesmo, e, composição farmacêutica
PL1850664T3 (pl)	2014-05-30	Formulacja kapsułki pestycydowej
FI20045070L (fi)	2005-09-12	Sovellukseen integroitu kiihdytysasiakas
BRPI0810399A2 (pt)	2014-11-04	Composto, composição farmacêutica que o contém e uso do mesmo
BRPI0911772A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso do composto.
DE602006001826D1 (de)	2008-08-28	Aerosolabgabevorrichtung
FI20065554A0 (fi)	2006-09-06	Käsittelylaite

Legal Events

Date	Code	Title	Description
2017-03-28	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-01-29	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-05-14	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2020-11-03	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-06-08	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-08-17	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.
2024-07-23	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.
2024-11-12	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2794 DE 23-07-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.